Cargando…

Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes

Oncolytic virotherapy is a promising new tool for cancer treatment, but direct lytic destruction of tumor cells is not sufficient and must be accompanied by strong immune activation to elicit anti-tumor immunity. We report here the creation of a novel replication-competent recombinant oncolytic herp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chouljenko, Dmitry V., Ding, Jun, Lee, I-Fang, Murad, Yanal M., Bu, Xuexian, Liu, Guoyu, Delwar, Zahid, Sun, Yi, Yu, Sheng, Samudio, Ismael, Zhao, Ronghua, Jia, William Wei-Guo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695276/ https://www.ncbi.nlm.nih.gov/pubmed/33182232 http://dx.doi.org/10.3390/biomedicines8110484

Ejemplares similares

Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1
por: Chouljenko, Dmitry V., et al.
Publicado: (2023)

VG161 activates systemic antitumor immunity in pancreatic cancer models as a novel oncolytic herpesvirus expressing multiple immunomodulatory transgenes
por: Shen, Yinan, et al.
Publicado: (2022)

Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus
por: Ding, Jun, et al.
Publicado: (2022)

Tumour-specific triple-regulated oncolytic herpes virus to target glioma
por: Delwar, Zahid M., et al.
Publicado: (2016)

Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?
por: Li, Yuwei, et al.
Publicado: (2020)

Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022)

Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
por: Zhang, Qing, et al.
Publicado: (2020)

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
por: Harper, James, et al.
Publicado: (2021)

Correction: Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
por: Zhang, Qing, et al.
Publicado: (2020)

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication
por: Flores, Erica B, et al.
Publicado: (2020)

β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer
por: Hu, Jiali, et al.
Publicado: (2021)

Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019)

Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells
por: Stevenson, A J, et al.
Publicado: (2000)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance
por: Russell, Luke, et al.
Publicado: (2018)

Innovative retargeted oncolytic herpesvirus against nectin4-positive cancers
por: Vannini, Andrea, et al.
Publicado: (2023)

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy
por: Dymova, Maya A., et al.
Publicado: (2022)

Enhancement of Chemokine Function as an Immunomodulatory Strategy Employed by Human Herpesviruses
por: Viejo-Borbolla, Abel, et al.
Publicado: (2012)

Antitumor Potential of Immunomodulatory Natural Products
por: Nuzzo, Genoveffa, et al.
Publicado: (2022)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
por: Zamarin, Dmitriy, et al.
Publicado: (2014)

Current strategies in engaging oncolytic viruses with antitumor immunity
por: Boagni, Drew Ashton, et al.
Publicado: (2021)

Antitumoral and Immunomodulatory Effect of Mahonia aquifolium Extracts
por: Andreicuț, Andra Diana, et al.
Publicado: (2019)

Bovine herpesvirus 4 based vector as a potential oncolytic-virus for treatment of glioma
por: Redaelli, Marco, et al.
Publicado: (2010)

Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
por: Farrera-Sal, Martí, et al.
Publicado: (2020)

Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development
por: Ho, Tiffany Y., et al.
Publicado: (2021)

Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
por: Zhang, Bin, et al.
Publicado: (2020)

Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus
por: Floyd, Warren, et al.
Publicado: (2023)

Immunomodulatory Arming Factors—The Current Paradigm for Oncolytic Vectors Relies on Immune Stimulating Molecules
por: Peters, Cole W. D., et al.
Publicado: (2021)

Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
por: Liu, Liqiong, et al.
Publicado: (2022)

Potent antitumor activity of oncolytic adenovirus expressing Beclin-1 via induction of autophagic cell death in leukemia
por: Tong, Yin, et al.
Publicado: (2013)

Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials
por: Kaufman, Howard L., et al.
Publicado: (2017)

Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy
por: Ahn, Hyo Min, et al.
Publicado: (2016)

Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma
por: Hughes, Tasha, et al.
Publicado: (2014)

Nanobody-based retargeting of an oncolytic herpesvirus for eliminating CXCR4(+) GBM cells: A proof of principle
por: Sanchez Gil, Judit, et al.
Publicado: (2022)

Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)

The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
por: Young, Brittany A., et al.
Publicado: (2013)

Combined Treatment with an Oncolytic Adenovirus and Antitumor Activity of Vincristine against Retinoblastoma Cells
por: Song, Xin, et al.
Publicado: (2012)

Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017)

Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity
por: Lin, Jing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9gb11dc9dtoksukfksv6h55a1p